| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 08/13/2013 | US8507654 Altered antibodies |
| 08/13/2013 | US8507442 Methods of use for an antibody against human frizzled receptors 1, 2. 5, 7 or 8 |
| 08/13/2013 | US8507438 Compositions and methods for the treatment of neurologic and psychiatric conditions |
| 08/13/2013 | US8507426 Peptides and related molecules that bind to TALL-1 |
| 08/13/2013 | US8507273 Gene encoding a multidrug resistance human P-glycoprotein homologue on chromosome 7p15-21 and uses thereof |
| 08/13/2013 | US8507249 Bacterial virulence factors and uses thereof |
| 08/13/2013 | US8507238 Polypeptides having cellobiohydrolase 1 activity and polynucleotides encoding same |
| 08/13/2013 | US8507214 Elisa kit for detecting lincomycin |
| 08/13/2013 | US8507196 Nucleic acid probe of human immunodeficiency virus type 1 (HIV-1), and a method and kit employing this probe for detecting the presence of nucleic acid of HIV-1 |
| 08/13/2013 | US8506960 Antibody molecule for human GM-CSF receptor alpha |
| 08/13/2013 | US8506958 Methods for treating TWEAK-related conditions |
| 08/13/2013 | CA2536354C Atopic dermatitis inducer |
| 08/13/2013 | CA2529647C Influenza hemagglutinin and neuraminidase variants |
| 08/13/2013 | CA2525781C Method for the prediction, diagnosis and differential diagnosis of alzheimer's disease |
| 08/13/2013 | CA2516777C Human cyclooxygenase-3 enzyme and uses thereof |
| 08/13/2013 | CA2498524C Immunoassays for specific determination of scca isoforms |
| 08/13/2013 | CA2477236C Amino-substituted sulfonanilides and derivatives thereof for treating proliferative disorders |
| 08/13/2013 | CA2469151C Immunocytokines with modulated selectivity |
| 08/13/2013 | CA2464121C Pregnancy-associated plasma protein-a2 (papp-a2) |
| 08/13/2013 | CA2438513C Modified anti-egfr antibodies with reduced immunogenicity |
| 08/13/2013 | CA2433316C Molecular antigen array |
| 08/13/2013 | CA2410224C Peptide conjugates modified n- and/or c-terminally by short charged peptide chains |
| 08/13/2013 | CA2372582C Novel fab fragment libraries and methods for their use |
| 08/13/2013 | CA2314319C Novel surface protein of neisseria meningitidis |
| 08/13/2013 | CA2258277C Characterization of granulocytic ehrlichia and methods of use |
| 08/13/2013 | CA2225377C Novel tgf-.beta. like cytokine |
| 08/13/2013 | CA2222643C Lawsonia intracellularis cultivation, anti-lawsonia intracellularis vaccines and diagnostic agents |
| 08/08/2013 | WO2013116686A1 Methods and products related to targeted cancer therapy |
| 08/08/2013 | WO2013116609A1 Humanized rodents that express heavy chains containing vl domains |
| 08/08/2013 | WO2013116296A1 Anti-asic1 antibodies and uses thereof |
| 08/08/2013 | WO2013116287A1 Anti-ig-e m1' antibodies and methods using same |
| 08/08/2013 | WO2013115962A2 Human streptococcus pneumoniae antibodies and uses therefor |
| 08/08/2013 | WO2013115410A2 Anti-phospholipase d4 antibody |
| 08/08/2013 | WO2013114885A1 Human monoclonal antibodies broadly protective against influenza b virus and methods of using the same |
| 08/08/2013 | WO2013114245A1 Process of modulating man5 and/or afucosylation content of glycoprotein composition |
| 08/08/2013 | WO2013113898A1 Process for reducing antibody aggregate levels and antibodies produced thereby |
| 08/08/2013 | WO2013113641A1 Use of nkp46 as a predictive biomarker for cancer treatment with adcc- enhanced antibodies |
| 08/08/2013 | WO2013113615A1 Bispecific antibody molecules with antigen-transfected t-cells and their use in medicine |
| 08/08/2013 | WO2013113107A1 Methods for promoting neuron survival, axonal growth and/or regeneration |
| 08/08/2013 | WO2013088348A3 Development of specific immunoassay critical reagents for pharmacokinetic assessments of peptide polymers in preclinical and clinical matrices |
| 08/08/2013 | WO2013078377A9 Anti-cd98 antibodies and methods of use thereof |
| 08/08/2013 | WO2013041845A3 Animals, repertoires & methods for the production of human antibodies |
| 08/08/2013 | WO2012175751A3 Fc variants with reduced effector functions |
| 08/08/2013 | US20130204069 Compositions and Methods of Treating Tumors |
| 08/08/2013 | US20130203970 Hepatocyte growth factor (hgf) binding proteins |
| 08/08/2013 | US20130203969 Use of small molecules in methods for purification of biomolecules |
| 08/08/2013 | US20130203968 Antibody-based diagnostics and therapeutics |
| 08/08/2013 | US20130203967 NOVEL COMPOSITIONS AND METHODS FOR TREATING IgE-MEDIATED DISORDERS |
| 08/08/2013 | US20130203966 NOVEL COMPOSITIONS AND METHODS FOR TREATING IgE-MEDIATED DISORDERS |
| 08/08/2013 | US20130203965 Binding Agents |
| 08/08/2013 | US20130203963 Hepatocyte growth factor (hgf) binding proteins |
| 08/08/2013 | US20130203962 Immunoglobulin g fc region binding polypeptide |
| 08/08/2013 | US20130203682 Rank ligand polypeptides |
| 08/08/2013 | US20130203164 Human Secreted Proteins |
| 08/08/2013 | US20130203111 Aldehyde Tags, Uses Thereof in Site-Specific Protein Modification |
| 08/08/2013 | US20130203079 Antibodies for the detection of integrin complexes in ffpe material |
| 08/08/2013 | US20130203076 Compositions and methods for detection of methadone metabolite |
| 08/08/2013 | US20130202678 Puf-a and related compounds for treatment of retinopathies and sight-threatening ophthalmologic disorders |
| 08/08/2013 | US20130202632 Minimal motifs of linear b-cell epitopes in l1 protein from human papillomavirus type 58 and their applications |
| 08/08/2013 | US20130202622 Method for the treatment of obesity |
| 08/08/2013 | US20130202621 Antibodies Directed To Alpha V Beta 6 And Uses Thereof |
| 08/08/2013 | US20130202618 Antibodies for the treatment of clostridium difficile-associated infection and disease |
| 08/08/2013 | US20130202617 Hemorrhagic feline calicivirus, calicivirus and method for preventing calicivirus infection or disease |
| 08/08/2013 | US20130202616 Compositions and methods for immunization against bacteria expressing a carbapenemase |
| 08/08/2013 | US20130202615 Anti-vegf antibodies and uses thereof |
| 08/08/2013 | US20130202608 Monoclonal antibody specific to major neutralizing epitope of influenza h5 hemagglutinin |
| 08/08/2013 | US20130202607 Anti-system asc amino acid transporter 2 (asct2) antibody |
| 08/08/2013 | US20130202606 Identification and Engineering of Antibodies with Variant Fc Regions and Methods of Using Same |
| 08/08/2013 | US20130202604 Therapeutic Uses of Monoclonal Antibodies to the Angiotensin-II Type-1 Receptor |
| 08/08/2013 | US20130202603 BISPECIFIC SINGLE CHAIN Fv ANTIBODY MOLECULES AND METHODS OF USE THEREOF |
| 08/08/2013 | US20130202600 Polypeptides And Methods For Modulating D1-D2 Dopamine Receptor Interaction And Function |
| 08/08/2013 | US20130202599 Novel immunoglobulins insertions, deletions, and substitutions |
| 08/08/2013 | US20130202598 Activatable toxin complexes comprising a cleavable inhibitory peptide |
| 08/08/2013 | US20130202597 Anti-serum albumin binding variants |
| 08/08/2013 | US20130202596 Processable Single Chain Molecules and Polypeptides Made Using Same |
| 08/08/2013 | US20130202593 Intracellular immunity |
| 08/08/2013 | US20130202592 Composition for the Anti-Cancer Metastasis Containing DLK1-Fc Fusion Protein as an Effective Ingredient |
| 08/08/2013 | US20130202591 Antibodies directed against il-17 |
| 08/08/2013 | US20130202576 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of histidyl-trna synthetases |
| 08/08/2013 | US20130202575 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-beta-trna synthetases |
| 08/08/2013 | US20130202574 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of valyl-trna synthetases |
| 08/08/2013 | US20130202552 Bimer or an oligomer of a dimer, trimer, quadromer or pentamer of recombinant fusion proteins |
| 08/08/2013 | US20130202527 Method of Treating Ovarian and Renal Cancer Using Antibodies Against T Cell Immunoglobulin Domain And Mucin Domain 1 (TIM-1) Antigen |
| 08/08/2013 | CA2861402A1 Stabilized aqueous antibody compositions |
| 08/08/2013 | CA2848985A1 C10rf32 antibodies, and uses thereof for treatment of cancer |
| 08/07/2013 | EP2623594A1 Antibody against human prostaglandin e2 receptor ep4 |
| 08/07/2013 | EP2623592A1 Antihuman ccr7 antibodies, hybridoma, nucleic acid, vector, cell, medicinal composition, and antibody-immobilized carrier |
| 08/07/2013 | EP2623517A1 Urine and serum biomarkers associated with diabetic nephropathy |
| 08/07/2013 | EP2623515A1 ANTI TNFalpha HUMANIZED ANTIBODY AND FRAGMENT ANTIGEN BINDING (FAB) AND USE THEREOF |
| 08/07/2013 | EP2622348A1 Means and methods for diagnosing cancer using an antibody which specifically binds to braf v600e |
| 08/07/2013 | EP2622091A2 Colon and pancreas cancer peptidomimetics |
| 08/07/2013 | EP2621956A2 Methods for the development of metzincin-selective catalytic cleft directed antibodies for therapeutic and diagnostic applications |
| 08/07/2013 | EP2621955A1 Anti-ceacam6 antibodies and uses thereof |
| 08/07/2013 | EP2621954A1 Anti-rori antibodies |
| 08/07/2013 | EP2621953A1 Biological materials related to c-met |
| 08/07/2013 | EP2621952A1 Anti-cd48 antibodies and uses thereof |
| 08/07/2013 | EP2621951A1 Combination of an agonistic anti-cd40 monoclonal antibody or a cd40 ligand and inactivated or attenuated bacteria for use in the treatment and/or prevention of mastitis |
| 08/07/2013 | EP2621950A2 Antibodies binding human collagen ii |
| 08/07/2013 | EP2621949A1 Polypeptides that bind to human complement component c5 |
| 08/07/2013 | EP2621948A1 Antibody specifically binding synovial microvasculature of arthritis patients |